Core Laboratories (NYSE:CLB) Trading Up 5.5% - Here's Why

Key Points

• Shares jumped 5.5% on Friday to about $17.33 (intraday high $17.50) while trading volume was ~161,435 shares, down ~59% from the average daily volume.
• Core beat expectations for the quarter with $0.21 EPS vs. $0.20 and revenue of $138.3M (vs. $130.4M), raised Q1 2026 EPS guidance to $0.110–$0.150, and reported revenue growth of 7% year‑over‑year.
• Analysts maintain a consensus "Hold" rating with an average price target of $12.50—well below the current share price—while the company has a market cap of ~$803M and a nominal dividend yield of 0.2%.

Core Laboratories Inc. (NYSE:CLB - Get Free Report)'s share price rose 5.5% during trading on Friday . The company traded as high as $17.50 and last traded at $17.3250. Approximately 161,435 shares traded hands during mid-day trading, a decline of 59% from the average daily volume of 393,920 shares. The stock had previously closed at $16.42.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a "hold (c)" rating on shares of Core Laboratories in a research note on Monday, December 29th. Four analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $12.50.

Core Laboratories Stock Up 6.2%

The firm has a market capitalization of $803.11 million, a price-to-earnings ratio of 26.05, a P/E/G ratio of 13.83 and a beta of 1.10. The company has a quick ratio of 1.57, a current ratio of 2.02 and a debt-to-equity ratio of 0.41. The company's 50 day moving average price is $17.84 and its 200 day moving average price is $15.91.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 EPS for the quarter, topping analysts' consensus estimates of $0.20 by $0.01. Core Laboratories had a return on equity of 12.18% and a net margin of 6.04%.The company had revenue of $138.26 million during the quarter, compared to analysts' expectations of $130.40 million. During the same quarter in the previous year, the firm posted $0.22 EPS. The firm's revenue was up 7.0% compared to the same quarter last year. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. As a group, research analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 9th. Investors of record on Monday, February 16th were issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, February 13th. Core Laboratories's dividend payout ratio (DPR) is 5.97%.

Institutional Investors Weigh In On Core Laboratories

Hedge funds have recently bought and sold shares of the stock. Ariel Investments LLC increased its holdings in shares of Core Laboratories by 25.5% during the 2nd quarter. Ariel Investments LLC now owns 12,976,463 shares of the oil and gas company's stock valued at $149,489,000 after purchasing an additional 2,634,438 shares in the last quarter. Disciplined Growth Investors Inc. MN grew its position in Core Laboratories by 9.7% during the third quarter. Disciplined Growth Investors Inc. MN now owns 5,969,860 shares of the oil and gas company's stock valued at $73,787,000 after buying an additional 528,976 shares during the period. Vanguard Group Inc. grew its position in Core Laboratories by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 3,079,882 shares of the oil and gas company's stock valued at $49,371,000 after buying an additional 32,492 shares during the period. State Street Corp increased its holdings in Core Laboratories by 3.3% in the fourth quarter. State Street Corp now owns 2,041,740 shares of the oil and gas company's stock valued at $32,729,000 after buying an additional 64,831 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in Core Laboratories by 10.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,229,611 shares of the oil and gas company's stock valued at $19,711,000 after buying an additional 118,535 shares in the last quarter. Hedge funds and other institutional investors own 97.81% of the company's stock.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company's portfolio spans two primary service lines: reservoir description and production enhancement.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.